• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Biomind Labs Inc.

    Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications
    From Biomind Labs Inc.
    Via Business Wire
    Tickers BMNDF
    Biomind Labs Doses First Subject in Phase I/IIa Clinical Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression
    From Biomind Labs Inc.
    Via Business Wire
    Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form
    From Biomind Labs Inc.
    Via Business Wire
    Biomind Labs to Advance a Phase II Clinical Trial on DMT for Treatment-Resistant Depression
    From Biomind Labs Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.